John Sorenson - Boston Scientific Ex Operations

All Insiders . Germany . 
Stock . Boston Scientific . Stakeholders . Insider . John Sorenson
BSX Stock  EUR 85.50  1.50  1.72%   

Insider

John Sorenson is Ex Operations of Boston Scientific
Age 55
Phone508 683 4000
Webhttps://www.bostonscientific.com

Boston Scientific Management Efficiency

The company has return on total asset (ROA) of 0.0393 % which means that it generated a profit of $0.0393 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0408 %, meaning that it generated $0.0408 on every $100 dollars invested by stockholders. Boston Scientific's management efficiency ratios could be used to measure how well Boston Scientific manages its routine affairs as well as how well it operates its assets and liabilities.
Boston Scientific has accumulated 8.91 B in total debt with debt to equity ratio (D/E) of 0.59, which is about average as compared to similar companies. Boston Scientific has a current ratio of 1.63, which is within standard range for the sector. Debt can assist Boston Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Boston Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Boston Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Boston to invest in growth at high rates of return. When we think about Boston Scientific's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Dirksen LehmanEdwards Lifesciences
N/A
Mary MorelandAbbott Laboratories
57
Alan DouvilleStryker
N/A
Sean LennonMedtronic PLC
N/A
Arnold PinkstonEdwards Lifesciences
64
Elizabeth McCombsBecton Dickinson and
47
Robert FordAbbott Laboratories
49
Michelle QuinnBecton Dickinson and
N/A
Francesca DeMartinoBecton Dickinson and
N/A
Daniel SalvadoriAbbott Laboratories
44
Hubert AllenAbbott Laboratories
57
JeanLuc LemercierEdwards Lifesciences
66
Christopher DelOreficeBecton Dickinson and
52
Michael MussallemEdwards Lifesciences
70
Larry WoodEdwards Lifesciences
57
Donald BoboEdwards Lifesciences
61
Andrea WainerAbbott Laboratories
53
Jennifer KirkMedtronic PLC
48
Ivan FongMedtronic PLC
62
Spencer StilesStryker
46
Robert CohenStryker
N/A
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts. BOSTON SCIENTIFIC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 38000 people. Boston Scientific (BSX) is traded on Frankfurt Exchange in Germany and employs 45,000 people.

Management Performance

Return On Equity0.0408
Return On Asset0.0393

Boston Scientific Leadership Team

Elected by the shareholders, the Boston Scientific's board of directors comprises two types of representatives: Boston Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Boston. The board's role is to monitor Boston Scientific's management team and ensure that shareholders' interests are well served. Boston Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Boston Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jodi Eddy, VP Officer
Vance Brown, Gen VP
Catherine Jennings, VP Interventions
Joseph Fitzgerald, Ex Cardiology
John Sorenson, Ex Operations
Daniel Brennan, Ex CFO
Jeffrey Mirviss, Ex Interventions
Michael Mahoney, Pres Chairman
Jonathan Monson, Global VP
Susan Lisa, VP Relations

Boston Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Boston Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity0.0408
Return On Asset0.0393
Profit Margin0.06 %
Operating Margin0.16 %
Current Valuation72.27 B
Shares Outstanding1.43 B
Shares Owned By Insiders0.20 %
Shares Owned By Institutions94.00 %
Price To Earning317.20 X
Price To Book3.80 X

Currently Active Assets on Macroaxis

VVisa Class A
GOOGAlphabet Inc Class C
GOOGAlphabet Inc Class C
MSFTMicrosoft
GMGeneral Motors

Other Information on Investing in Boston Stock

Boston Scientific financial ratios help investors to determine whether Boston Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boston with respect to the benefits of owning Boston Scientific security.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY